Ruprecht-karls-universitaet Heidelberg

Deutsches Krebsforschungszentrum

Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts

Universitat Heidelberg

The European Atomic Energy Community (euratom), Represented by the European Commission

Ruprecht-karls-universitat Heidelberg

Frederik Giesel

Uwe Haberkorn

Matthias Eder

Klaus Kopka

Michael Eisenhut

Martina Benesova

Ulrike Bauder-Wuest

Martin Schaefer

Jens Cardinale

Christos Apostolidis

Jürgen Debus

Clemens Kratochwil

Alfred Morgenstern

Juergen Debus

Rainer Neumann

Frank Bruchertseifer

Christian Zechmann

Hendrik Von Tengg-Kobligk

Marc Muenter

Martin Schafer

Marc MÜNTER

The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers and imaging agents for various disease states of prostate cancer.

F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer

The invention relates to a method for treating PSMA expressing cancers, wherein the method comprises administering to patient in need thereof an effective amount of one or more Ac-225-radiopharmaceuticals, wherein the effective amount of said one or more Ac-225-radiopharmaceuticals is administered as a dosage of from 25 kBq to 400 kBq/kg of body weight of said patient or wherein the effective amount of said one or more Ac-225-radiopharmaceuticals is administered as a unitary dosage of from 3 MBq to 30 MBq to said patient.

Treatment of PMSA expressing cancers

18F&#x2014;tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer

A method to derive anatomical structures from non-invasive imaging technologies is provided. Non-invasive imaging technologies are computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), surface scans and others. Imaging data obtained by a non-invasive technology is used to create a surface contour. The imaging data is transmitted to a rapid prototyping apparatus as readable data. With this readable data the rapid prototyping apparatus establishes a positive or negative surface model, such as a fixation device, a mask, or a prosthesis, or other instruments for medical purposes.

Method to derive anatomical and/or pathological structures from data of imaging technologies

Growing community of inventors

Heidelberg, Germany

Frederik Giesel